Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Method for establishing prediction model for survival benefit of gallbladder cancer patient after chemoradiotherapy

A technology for predicting models and establishing methods, which can be applied to patient-specific data, computer-aided medical procedures, health index calculation, etc. , easy to repeat, easy to operate effect

Pending Publication Date: 2021-10-29
ZHONGSHAN HOSPITAL FUDAN UNIV
View PDF4 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] However, due to the low incidence of GBC, the indications for adjuvant therapy for GBC and the differences in the efficacy of postoperative chemotherapy and chemotherapy combined with radiotherapy are still controversial.
At present, in the prior art, there is a lack of in-depth research on the differences in the efficacy of postoperative chemotherapy and chemotherapy combined with radiotherapy. At present, there is no good method to predict the prognosis of GBC patients receiving chemotherapy or chemotherapy combined with radiotherapy, and the prognosis cannot be reliably analyzed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for establishing prediction model for survival benefit of gallbladder cancer patient after chemoradiotherapy
  • Method for establishing prediction model for survival benefit of gallbladder cancer patient after chemoradiotherapy
  • Method for establishing prediction model for survival benefit of gallbladder cancer patient after chemoradiotherapy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0053] The following will clearly and completely describe the technical solutions in the embodiments of the present invention with reference to the drawings in the embodiments of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts shall fall within the protection scope of the present invention.

[0054] This example relates to a method for establishing a predictive model for the survival benefit of patients with gallbladder cancer after radiotherapy and chemotherapy. The process is as follows figure 1 shown, including:

[0055] Step 1: Obtain clinical and pathological data of patients with gallbladder cancer, including: patient's gender, age, degree of tumor differentiation, TNM stage, surgical method, number of dissected lymph nodes, postoperative...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a method for establishing a prediction model for survival benefit of a gallbladder cancer patient after chemoradiotherapy. The method comprises the steps of acquiring clinical and pathological data of the gallbladder cancer patient; dividing the acquired data into a plurality of groups of data according to the TNM stages, and respectively judging whether the patient in each stage is benefited from adjuvant therapy or not; dividing the data corresponding to the TNM stages into a modeling group and an internal verification group; analyzing the prediction capability of clinical and pathological variables of the modeling group data on the total survival time OS through a single-factor COX risk scale model, and screening risk factors which significantly influence the total survival time OS of the patient in the modeling group; incorporating the screened risk factors into a multi-factor COX risk scale model for analysis, and screening out influence variables significantly influencing the total survival time OS of the patient; according to the obtained influence variables, drawing a column graph used for predicting the total survival time OS, and obtaining a prediction model; and verifying the model. Compared with the prior art, the method has the advantages of providing credible prediction and analysis results for the GBC patient, being simple and convenient to operate and the like.

Description

technical field [0001] The invention relates to the technical field of prognosis evaluation, in particular to a method for establishing a prediction model for the survival benefit of gallbladder cancer patients after radiotherapy and chemotherapy. Background technique [0002] Gallbladder cancer (GBC) is the fifth most common gastrointestinal tumor, with an annual incidence of 2 to 27 per 100,000. Although relatively rare, GBC is the most aggressive malignancy of the biliary tract, with a 5-year survival rate of approximately 5%. Surgical resection is the only treatment for GBC. However, the recurrence rate after complete resection is high, often leading to poor prognosis. Therefore, postoperative chemotherapy, chemotherapy combined with radiotherapy and other adjuvant treatments are applied to GBC patients to improve the prognosis of patients. [0003] However, due to the low incidence of GBC, the indications for adjuvant therapy for GBC and the differences in the effica...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G16H50/30G16H10/60G16H10/20
CPCG16H50/30G16H10/60G16H10/20
Inventor 刘厚宝万文泽倪小健
Owner ZHONGSHAN HOSPITAL FUDAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products